A combination of cis-2-decenoic acid and antibiotics eradicates pre-established catheter-associated biofilms

Journal of Medical Microbiology

Volumn 63, Issue , 2014, Pages 1509-1516

  Rahmani Badi, Azadeh ^a   Sepehr, Shayesteh ^a   Mohammadi, Parisa ^a   Soudi, Mohammad Reza ^a   Babaie Naiej, Hamta ^a   Fallahi, Hossein ^b,c  

^a ALZAHRA UNIVERSITY   (Iran)

^b RAZI UNIVERSITY   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Catheter associated urinary tract infection; CAUTI; CDA; Cis 2 decenoic acid; EPS; Extracellular polymeric substance

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; CIS 2 DECENOIC ACID; CRYSTAL VIOLET; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; 2-DECENOIC ACID; ANTIINFECTIVE AGENT; MONOUNSATURATED FATTY ACID;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL VIABILITY; BACTERIOPLANKTON; BACTERIUM CULTURE; BIOFILM; CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FLUORESCENCE MICROSCOPY; IMAGE ANALYSIS; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MIXED CELL CULTURE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SURFACE PROPERTY; URINARY CATHETER; URINARY TRACT INFECTION; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; FATTY ACIDS, MONOUNSATURATED; HUMANS; KLEBSIELLA PNEUMONIAE; URINARY CATHETERS;

EID: 84908266928     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.075374-0     Document Type: Article

References (30)

1. Anderl, J. N., Franklin, M. J. & Stewart, P. S. (2000). Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 44, 1818–1824.
2. Barraud, N., Hassett, D. J., Hwang, S. H., Rice, S. A., Kjelleberg, S. & Webb, J. S. (2006). Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol 188, 7344–7353.
3. Campanac, C., Pineau, L., Payard, A., Baziard-Mouysset, G. & Roques, C. (2002). Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother 46, 1469–1474.
4. Chambers, L. D., Stokes, K. R., Walsh, F. C. & Wood, R. J. K. (2006). Modern approaches to marine antifouling coatings. Surf Coat Technol 201, 3642–3652.
5. Cloete, T. E., Jacobs, L. & Bro¨ zel, V. S. (1998). The chemical control of biofouling in industrial water systems. Biodegradation 9, 23–37.
6. CLSI (2006). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard, 7th edn, 7-17. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Cobrado, L., Azevedo, M. M., Silva-Dias, A., Ramos, J. P., Pina-Vaz, C. & Rodrigues, A. G. (2012). Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? J Antimicrob Chemother 67, 1159–1162.
8. Cobrado, L., Silva-Dias, A., Azevedo, M. M., Pina-Vaz, C. & Rodrigues, A. G. (2013). In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections. J Antimicrob Chemother 68, 126–130.
9. Dalgaard, P. (1995). Qualitative and quantitative characterization of spoilage bacteria from packed fish. Int J Food Microbiol 26, 319–333.
10. Darouiche, R. O., Smith, J. A., Jr, Hanna, H., Dhabuwala, C. B., Steiner, M. S., Babaian, R. J., Boone, T. B., Scardino, P. T., Thornby, J. I. & Raad, I. I. (1999). Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54, 976–981.
11. Davies, D. G. & Marques, C. N. (2009). A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 191, 1393–1403.
12. Desbois, A. P. & Smith, V. J. (2010). Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 85, 1629–1642.
13. Desbois, A. P., Lebl, T., Yan, L. & Smith, V. J. (2008). Isolation and structural characterisation of two antibacterial free fatty acids from the marine diatom, Phaeodactylum tricornutum. Appl Microbiol Biotechnol 81, 755–764.
14. Flemming, H. C. & Wingender, J. (2010). The biofilm matrix. Nat Rev Microbiol 8, 623–633.
15. Fux, C. A., Costerton, J. W., Stewart, P. S. & Stoodley, P. (2005). Survival strategies of infectious biofilms. Trends Microbiol 13, 34–40.
16. Griffith, D. P., Musher, D. M. & Itin, C. (1976). Urease. The primary cause of infection-induced urinary stones. Invest Urol 13, 346–350.
17. Hancock, V., Dahl, M. & Klemm, P. (2010). Abolition of biofilm formation in urinary tract Escherichia coli and Klebsiella isolates by metal interference through competition for Fur. Appl Environ Microbiol 76, 3836–3841.
18. Jennings, J. A., Courtney, H. S. & Haggard, W. O. (2012). Cis-2- decenoic acid inhibits S. aureus growth and biofilm in vitro: a pilot study. Clin Orthop Relat Res 470, 2663–2670.
19. Johnson, J. R., Kuskowski, M. A. & Wilt, T. J. (2006). Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 144, 116–126.
20. Kenny, J. G., Ward, D., Josefsson, E., Jonsson, I. M., Hinds, J., Rees, H. H., Lindsay, J. A., Tarkowski, A. & Horsburgh, M. J. (2009). The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS ONE 4, e4344.
21. Musk, D. J., Jr & Hergenrother, P. J. (2008). Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung. J Appl Microbiol 105, 380–388.
22. Ramos, E. R., Reitzel, R., Jiang, Y., Hachem, R. Y., Chaftari, A. M., Chemaly, R. F., Hackett, B., Pravinkumar, S. E., Nates, J. & Other Authors (2011). Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 39, 245–251.
23. Stamm, W. E. (1991). Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 91 (3B), 65S–71S.
24. Stickler, D. J. (2008). Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 5, 598–608.
25. Stoodley, P., Sauer, K., Davies, D. G. & Costerton, J. W. (2002). Biofilms as complex differentiated communities. Annu Rev Microbiol 56, 187–209.
26. Takigawa, H., Nakagawa, H., Kuzukawa, M., Mori, H. & Imokawa, G. (2005). Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology 211, 240–248.
27. Tambyah, P. A., Knasinski, V. & Maki, D. G. (2002). The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 23, 27–31.
28. Ulett, G. C., Mabbett, A. N., Fung, K. C., Webb, R. I. & Schembri, M. A. (2007). The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. Microbiology 153, 2321–2331.
29. Walters, M. C, Roe, F., Bugnicourt, A., Franklin, M. J. & Stewart, P. S. (2003). Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47, 317–323.
30. Yang, L., Liu, Y., Wu, H., Song, Z., Høiby, N., Molin, S. & Givskov, M. (2012). Combating biofilms. FEMS Immunol Med Microbiol 65, 146–157.